Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: The Clinics: Internal Medicine, cartea 35-4
Editat de Jennifer R. Brown?en Limba Engleză Hardback – 14 iul 2021
Din seria The Clinics: Internal Medicine
- 5% Preț: 546.14 lei
- 5% Preț: 591.22 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.09 lei
- 5% Preț: 547.44 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.62 lei
- 5% Preț: 518.67 lei
- 5% Preț: 518.96 lei
- 5% Preț: 519.44 lei
- 5% Preț: 517.98 lei
- 5% Preț: 519.60 lei
- 5% Preț: 573.62 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 282.65 lei
- 5% Preț: 403.05 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.01 lei
- 5% Preț: 463.34 lei
- 5% Preț: 403.45 lei
- 5% Preț: 460.60 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.69 lei
- 5% Preț: 462.57 lei
- 5% Preț: 295.31 lei
- 5% Preț: 448.61 lei
- 5% Preț: 506.70 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.15 lei
- 5% Preț: 518.39 lei
- 5% Preț: 609.55 lei
- 5% Preț: 518.21 lei
- 5% Preț: 518.09 lei
- 21% Preț: 450.00 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.44 lei
- 5% Preț: 576.17 lei
- 5% Preț: 577.92 lei
- 5% Preț: 576.94 lei
- 5% Preț: 570.07 lei
- 5% Preț: 576.11 lei
- 5% Preț: 686.25 lei
- 5% Preț: 547.43 lei
- 5% Preț: 764.42 lei
- 5% Preț: 576.27 lei
- 5% Preț: 579.22 lei
Preț: 527.19 lei
Preț vechi: 554.95 lei
-5% Nou
Puncte Express: 791
Preț estimativ în valută:
100.95€ • 104.02$ • 84.71£
100.95€ • 104.02$ • 84.71£
Carte tipărită la comandă
Livrare economică 15 februarie-01 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323896924
ISBN-10: 0323896928
Pagini: 240
Dimensiuni: 152 x 229 mm
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323896928
Pagini: 240
Dimensiuni: 152 x 229 mm
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic LeukemiaThe Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical ImplicationsPrognostic and Predictive Implications of Cytogenetics and GenomicsGenomics of Resistance to Targeted TherapiesFirst-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and BeyondBruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond IbrutinibShould Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton's Tyrosine Kinase InhibitorsThe Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic LeukemiaCan Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond